559 related articles for article (PubMed ID: 9719121)
41. Treatment of locally recurrent carcinoma of the nasopharynx.
Fu KK; Newman H; Phillips TL
Radiology; 1975 Nov; 117(2):425-31. PubMed ID: 170644
[TBL] [Abstract][Full Text] [Related]
42. Treatment results of 59 young patients with nasopharyngeal carcinoma.
Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
[TBL] [Abstract][Full Text] [Related]
43. Recurrent nasopharyngeal carcinoma: current management approaches.
Smee RI; Meagher NS; Broadley K; Ho T; Williams JR; Bridger GP
Am J Clin Oncol; 2010 Oct; 33(5):469-73. PubMed ID: 19935385
[TBL] [Abstract][Full Text] [Related]
44. 10-year survival rate for patient with nasopharyngeal carcinoma after radiation therapy. Clinical analysis of 367 cases.
Chen CQ; Liu TF; Zhao S
Chin Med J (Engl); 1989 Apr; 102(4):239-42. PubMed ID: 2507236
[TBL] [Abstract][Full Text] [Related]
45. Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis.
Sarin R; Norman AR; Steel GG; Horwich A
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):713-22. PubMed ID: 9240637
[TBL] [Abstract][Full Text] [Related]
46. [Primary radiotherapy of nasopharyngeal carcinoma].
Rübe C; Grevers G; Grimminger H; Wendt T; Rohloff R
Laryngorhinootologie; 1995 Feb; 74(2):103-7. PubMed ID: 7710601
[TBL] [Abstract][Full Text] [Related]
47. Treatment of recurrent bronchial carcinoma: the role of high-dose-rate endoluminal brachytherapy.
Hauswald H; Stoiber E; Rochet N; Lindel K; Grehn C; Becker HD; Debus J; Harms W
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):373-7. PubMed ID: 19836162
[TBL] [Abstract][Full Text] [Related]
48. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
[TBL] [Abstract][Full Text] [Related]
49. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
Nakamura T; Kodaira T; Tachibana H; Tomita N; Tomoda T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Fuwa N
Jpn J Clin Oncol; 2008 Dec; 38(12):803-9. PubMed ID: 18840881
[TBL] [Abstract][Full Text] [Related]
50. Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer.
Roeder F; Zwicker F; Saleh-Ebrahimi L; Timke C; Thieke C; Bischof M; Debus J; Huber PE
Radiat Oncol; 2011 Mar; 6():22. PubMed ID: 21356126
[TBL] [Abstract][Full Text] [Related]
51. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence.
Lee AW; Law SC; Foo W; Poon YF; Cheung FK; Chan DK; Tung SY; Thaw M; Ho JH
Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):773-82. PubMed ID: 8344845
[TBL] [Abstract][Full Text] [Related]
52. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma.
Kwong DL; Wei WI; Cheng AC; Choy DT; Lo AT; Wu PM; Sham JS
Cancer; 2001 Mar; 91(6):1105-13. PubMed ID: 11267955
[TBL] [Abstract][Full Text] [Related]
53. A retrospective comparison of robotic stereotactic body radiotherapy and three-dimensional conformal radiotherapy for the reirradiation of locally recurrent nasopharyngeal carcinoma.
Ozyigit G; Cengiz M; Yazici G; Yildiz F; Gurkaynak M; Zorlu F; Yildiz D; Hosal S; Gullu I; Akyol F
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e263-8. PubMed ID: 21514737
[TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of keratinization in nasopharyngeal carcinoma.
Reddy SP; Raslan WF; Gooneratne S; Kathuria S; Marks JE
Am J Otolaryngol; 1995; 16(2):103-8. PubMed ID: 7540805
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy.
Xiao W; Liu S; Tian Y; Guan Y; Huang S; Lin C; Zhao C; Lu T; Han F
PLoS One; 2015; 10(4):e0125351. PubMed ID: 25927527
[TBL] [Abstract][Full Text] [Related]
56. Prognostic factors for loco-regional control and outcome of re-irradiation for patients with poorly-differentiated squamous cell carcinoma of the nasopharynx.
Mitsuhashi N; Sakurai H; Takahashi M; Maebayashi K; Tamaki Y; Hashida I; Akimoto T; Nakamoto S; Takahashi T; Hayakawa K
Jpn J Clin Oncol; 1995 Jun; 25(3):72-8. PubMed ID: 7596051
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors and outcome for nasopharyngeal carcinoma.
Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
[TBL] [Abstract][Full Text] [Related]
58. [Prognostic factors in nasopharyngeal carcinoma in childhood and adolescence].
Cao KJ; Li Y; Xie GF; Hong MH
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):134-7. PubMed ID: 16750020
[TBL] [Abstract][Full Text] [Related]
59. Pulsed low dose rate brachytherapy for uterine cervix carcinoma.
Rogers CL; Freel JH; Speiser BL
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):95-100. PubMed ID: 9989519
[TBL] [Abstract][Full Text] [Related]
60. Dose escalation for patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone.
Yeh SA; Huang YJ
Am J Clin Oncol; 2007 Aug; 30(4):401-5. PubMed ID: 17762441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
